The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Locus coeruleus neurons contain norepinephrine-derived neuromelanin (227, 228); the dorsal motor nucleus of vagus contains neuromelanin that may be dopaminergic (202); and the raphe nuclei contain neuromelanin derived from their neurotransmitter, serotonin.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [228]
In the citing paper
“In healthy ageing, selective accumulation of iron occurs in several brain regions and cell types, with iron mainly bound within ferritin and neuromelanin (panel).5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Neuromelanin is present in neurons as neuromelanin-iron complexes in which the iron content varies depending on the neurons in each brain area.6,53”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Regional distribution of total iron in a healthy adult brain is heterogeneous; the highest iron concentrations were detected in the basal ganglia (putamen, globus pallidus, and caudate nucleus), whereas low concentrations were detected in the cortical grey matter, white matter, midbrain, and cerebellum, and the lowest iron concentrations were in the pons, locus coeruleus, and medulla.6,43,45–47”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
Connor, J. R., Boyer, P. J., Menzies, S. L., Dellinger, B., Allen, R. P., Ondo, W. G., & Earley, C. J. (2003) · Neurology · doi:10.1212/01.wnl.0000078887.16593.12 · Cited by 548
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
Research works printed but not linked: 5
- Arnsten, A. F. & Goldman-Rakic, P. S. (1987) J. Neural Transm. 24, 317-324.
- 10.1002/1531-8249(199910)46:4<598::aid-ana7>3.0.co;2-f · DOI
- Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L. & Lucius, R. (2003) FASEB J. 17, 500-502.12631585
- Blain, I., Slama, P., Giorgi, M., Tron, T. & Reglier, M. (2002) J. Biotechnol. 90, 95-112.12069196
- Marttila, R. J., Viljanen, M., Toivonen, E., Lorentz, H. & Rinne, U. K. (1990) Adv. Neurol. 53, 141-144.2239455
Cited by
Items 401–500 of 533
Melanin and Neuromelanin in the Nervous System
Tolleson, W. H. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_3392 · Cited by 4
Neuromelanin, iron and MRI measurements in midbrain tissues of Parkinson’s and Alzheimer’s subjects
Zucca, F. A., Cassidy, C., Sturini, M., Tuominen, L. J., Adorni, F., Cheung, V., Casella, L., Sulzer, D., Pezzoli, G., Isaias, I. U., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1672578 · Cited by 3
Self-citationKusama, M., Kimura, Y., Yoneyama, M., Namiki, T., Tamaru, T., Miyagi, K., & Sato, N. (2024) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2023-0095 · Cited by 3
Phenotypic and Clinical Traits That Correlate with Cognitive Impairment in Caucasian Females
Reisz, C., Figenshau, K., Cheng, A., & Elfagir, A. (2021) · Women s Health Reports · doi:10.1089/whr.2021.0007 · Cited by 3
Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?
Savoie, F.-A., Arpin, D. J., & Vaillancourt, D. E. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230801140648 · Cited by 3
Aganj, I., Mora, J., Fischl, B. R., & Augustinack, J. C. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1375530 · Cited by 3
Soft modeling strategies at work to follow and rationalize dopamine oxidative polymerization
Schifano, F., Magnaghi, L. R., Sturini, M., Monzani, E., Casella, L., & Biesuz, R. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111141 · Cited by 3
Substantia nigra degeneration in spinocerebellar ataxia 2 and 7 using neuromelanin‐sensitive imaging
Chougar, L., Coarelli, G., Lejeune, F., Ziegner, P., Gaurav, R., Biondetti, E., Sayah, S., Hilab, R., Dagher, A., Dürr, A., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70035 · Cited by 3
Neuromelanin and Parkinson’s Disease
Greco, G. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_12 · Cited by 3
Tang, F., Liu, H., Zhang, X. J., Zheng, H., Dai, Y. M., Zheng, L. Y., Yang, W. H., Du, Y. Y., & Liu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.865825 · Cited by 2
Neuromelanin and Parkinson’s Disease
Greco, G. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_12 · Cited by 2
Filimontseva, A., Cuadros, T., Chatterton, Z., Burke, A., Mahabadian, A. A., Compte, J., Fu, Y., Vila, M., & Halliday, G. M. (2025) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70033 · Cited by 2
McNamara, A., Carr, L. M., Baetu, I., Jenkinson, M., & Collins‐Praino, L. E. (2026) · Parkinson s Disease · doi:10.1155/padi/2703114 · Cited by 2
Blunted response of caudal locus coeruleus to arousing stimuli in Parkinson’s disease
Lund, A. E., Madelung, C. F., Madsen, K. H., Thomsen, B. L. C., Løkkegaard, A., Meder, D., & Siebner, H. R. (2026) · Brain · doi:10.1093/brain/awag106 · Cited by 2
Lactoperoxidase is a candidate for mediating neuromelanin formation in the human substantia nigra
Tóth, Z., Baráth, M., Pape, V. F. S., Sípos, K., Boros, A. P., Durst, M., Várnai, P., Sirokmány, G., & Geiszt, M. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2531597123 · Cited by 2
Küpper, C., Levin, J., & Klopstock, T. (2017) · Neuroradiologie Scan · doi:10.1055/s-0043-103529 · Cited by 2
Iron-Induced Dopaminergic Cell Death In Vivo as a Model of Parkinson’s Disease
Gerlach, M., Double, K. L., & Riederer, P. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_100-1 · Cited by 2
Les oligoéléments et les minéraux
Ferry, M. (2012) · Elsevier eBooks · doi:10.1016/b978-2-294-71125-1.00018-x · Cited by 2
The Role of Copper Ion and the Ubiquitin System in Neurodegenerative Disorders
Arnesano, F. (2010) · Wiley eBooks · doi:10.1002/9783527630516.ch1 · Cited by 2
Iron Metabolism in Parkinson’s Disease
Gao, G., You, L., & Chang, Y. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00255 · Cited by 2
Human nigral and liver iron — comparison by Mössbauer spectroscopy, electron microscopy and ELISA
Gałązka-Friedman, J., Bauminger, E. R., Friedman, A., Koziorowski, D., & Szlachta, K. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-49850-6_42 · Cited by 2
Treatment of Neurodegenerative Diseases by Chelators
Ward, R. J., Dexter, D. T., & Crichton, R. R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623892-00153 · Cited by 2
Bentea, L., Ölveczky, P. C., & Bentea, E. (2014) · NORA - Norwegian Open Research Archives · Cited by 2
Why Is the Study of Iron Important for Magnetic Resonance Imaging?
Killiany, R. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e31802c14e6 · Cited by 2
González‐Escamilla, G., Othman, A. E., Rotaru, L., Winter, Y., & Groppa, S. (2024) · Neuromethods · doi:10.1007/978-1-0716-4083-8_11 · Cited by 1
Heger, L. M., Kertess, L., Kaufhold, C., Gubinelli, F., Cardona‐Alberich, A., Özata, G., Müller, S. A., Tschirner, S. K., Stehling, O., Schifferer, M., et al. (2025) · Movement Disorders · doi:10.1002/mds.70029 · Cited by 1
Self-citationMolecular programs in human locus coeruleus link APOE and neuromelanin to Alzheimer’s vulnerability
Mulvey, B., Divecha, H. R., Tippani, M., Bach, S. V., Bharadwaj, R. A., Rosario, I. D., Maguire, S. E., Miller, R. A., Salisbury, A. J., Chandra, A., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03073-8 · Cited by 1
Kuang, C., Liu, W. V., Li, L., Liu, C., & Zha, Y. (2025) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-2025-57 · Cited by 1
Neuromelanin: Bridging catecholamine metabolism and neurodegeneration in Parkinson's disease
González-Sepúlveda, M., Cladera-Sastre, J. M., & Vila, M. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00002-6 · Cited by 1
Iron-Induced Dopaminergic Cell Death In Vivo as a Model of Parkinson’s Disease
Gerlach, M., Double, K. L., & Riederer, P. F. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_100 · Cited by 1
Application of Iron Related Magnetic Resonance Imaging in the Neurological Disorders
Kim, T., & Lee, J. (2014) · Korean Journal of Clinical Neurophysiology · doi:10.14253/kjcn.2014.16.1.1 · Cited by 1
Youdim, M. B. H., Weinreb, O., Mandel, S. A., & Amit, T. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch26 · Cited by 1
The Environmental Contribution to Redox Dyshomeostasis in Parkinson’s Disease
Garza-Lombó, C., & Franco, R. (2022) · Molecular and integrative toxicology · doi:10.1007/978-3-030-87451-3_4 · Cited by 1
Capucciati, A., Monzani, E., Sturini, M., Nicolis, S., Zucca, F. A., Bubacco, L., Bortolus, M., Zecca, L., & Casella, L. (2022) · Angewandte Chemie · doi:10.1002/ange.202204787 · Cited by 1
Self-citationRedox Mechanism of Neurotoxicity by a Serotonin–Acrolein Polymeric Melanoid
Murphy, M. M., Miller, E. D., Fibuch, E. E., & Seidler, N. W. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9173-3 · Cited by 1
Murphy, J. M. (2018) · TigerPrints (Clemson University) · Cited by 1
Tona, K. (2020) · Leiden Repository (Leiden University) · Cited by 1
Wiltschko, W., Kramer, B., Winklhofer, M., Lohmann, K. J., Lohmann, C. M. F., Fransson, P., Ioannides, A. A., Boeke, H., Salcedo, E., Restrepo, D., et al. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_13 · Cited by 1
Otsuka, F. S. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2023.tde-10112023-150646 · Cited by 1
The Cognitive Impact of Chronic Low-level Carbon Monoxide Exposure in Older Adults
Cheshire, B. (2023) · Lancaster EPrints (Lancaster University) · doi:10.17635/lancaster/thesis/1909 · Cited by 1
Billaud, J. (2021) · theses.fr (ABES) · doi:10.70675/6b525e83zc9a4z4a6fz8fb2z0c5451bb285e · Cited by 1
Dukes, A. A. (2007) · D-Scholarship@Pitt (University of Pittsburgh)
Mitochondrial Involvement in Neurodegeneration and Aging
Pickrell, A. M. (2012)
Novel Synchrotron-Based Analyses of Metal Pathology in Friedreich’s Ataxia
Popescu, B. F. G. (2009) · University Library - University of Saskatchewan (University of Saskatchewan)
Faust, K. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8019
Effects of pharmaceutical modulation of protein aggregation on lifespan in Caenorhabditis elegans
Klang, I. M. (2015) · Figshare
Neurotoxicidade do ferro na fisiopatologia da doença de Parkinson
Calou, I. B. F., Cerqueira, G. D. S., & Siqueira, R. M. P. (2015) · Revista Intertox de Toxicologia Risco Ambiental e Sociedade · doi:10.22280/revintervol8ed1.193
Persson, N. (2015) · DiVA (Stockholm University)
Muralidhar, L. H. (2005) · CFTRI Institutional Repository
Die Rolle von Neuromelanin in der Pathogenese desidiopathischen Parkinson Syndroms
Geick, S. (2011) · MACAU: Open Access Repository of Kiel University
Aus der Neurologischen Klinik und Poliklinik der Ludwig
München, M.-U., & Dieterich, M. (2011)
Role for Reactive Oxygen Species in Methamphetamine Modulation of Dopamine Release in the Striatum
Hedges, D. M. (2016) · ScholarsArchive (Brigham Young University)
Ultra-High Field Magnetic Resonance Imaging for Stereotactic Neurosurgery
Lau, J. C. (2019) · Scholarship@Western (Western University)
2, U. D. L., Reuck, J. D., Durieux, N., Cordonnier, C., Bordet, R., Leys, D., Pasquier, F., Auger, F., Maurage, C., & Deramecourt, V. (2019) · Acta Scientific Neurology · doi:10.31080/asne.2019.02.0092
T 1q and T 2q MRI in the evaluation of Parkinson's disease
Tuite, J., Michaeli, S., Liimatainen, T., Hanson, T., Nixon, J. P., Craniofacial, M., & Kotz, C. M. (2010)
Fujiwara, Y., Hirai, T., Ueda, T., Kumazoe, H., & Ito, S. (2020) · Acta Radiologica · doi:10.1177/0284185120920806
Barber, T. R. (2020) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-4jgonywg5
The role of biometals in the neuropathology of Parkinson’s disease
Genoud, S. (2020) · The Sydney eScholarship Repository (The University of Sydney)
Ohiomokhare, S. (2020) · Durham e-Theses (Durham University)
Copper and zinc level alterations in the brain structures in Parkinson’s and Alzheimer’s diseases
Николаевич, С. В., & Худоерков, Р. М. (2020) · CLINICAL AND EXPERIMENTAL MORPHOLOGY · doi:10.31088/cem2020.9.3.21-26
Garguilo, J. (2006) · NCSU Libraries Repository (North Carolina State University Libraries)
Levodopa Therapy for the Treatment of Parkinson’s Disease
Hattori, N. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_225-1
Hypoxia-inducible factor 2α but not hypoxia-inducible factor-1α increases iron traffic in astrocytesPreprint
Xu, M., Chen, Z., Ma, X., Xu, H., Fan, C., Wang, J., & Xie, J. (2020) · doi:10.21203/rs.3.rs-24083/v1
Recapitulating Parkinson’s disease pathology in a three-dimensional neural cell culture model
Taylor-Whiteley, T. R. (2019) · Sheffield Hallam University · doi:10.7190/shu-thesis-00321 · Cited by 1
Fehr, T. K. (2021) · uO Research (University of Ottawa) · doi:10.20381/ruor-25865
Vanna, R. (2012) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/vanna-renzo_phd2012-02-08
Electrochemical Studies on the Biopigment Eumelanin
Xu, R. (2020) · PolyPublie (École Polytechnique de Montréal) · doi:10.13140/rg.2.2.21418.24004
Kim, T. H., & 이재형 (2014) · Annals of Clinical Neurophysiology
Vavougios, G. D., Zarogiannis, S. G., Barh, D., Breza, M., Krogfelt, K. A., Stamoulis, G. I., & Gourgoulianis, K. I. (2021) · Brain Disorders · doi:10.1016/j.dscb.2021.100025
Mecanismes de toxicitat de la dopamina en cèl·lules de neuroblastoma humà SH-SY5Y
Xavier, P. G. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Николаевич, С. В., Худоерков, Р. М., Воронков, Д. Н., & Sobolev, V. B. (2022) · Russian Journal of Archive of Pathology · doi:10.17116/patol20228402113
Mitochondrial dysfunction and its consequences in the context of neurodegeneration
Key, J. (2021) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.62414
Morley, J. E. (2007) · Nutrition and disease prevention · doi:10.1201/9781420005493.ch11
Iron as a risk factor in neurological diseases
Galazka-Friedman, J. (2008) · Springer eBooks · doi:10.1007/978-3-540-78697-9_5
Hypoxia-inducible factor-2α but not hypoxia-inducible factor-1α increases iron traffic in astrocytesPreprint
Xu, M., Chen, Z., Ma, X., Xu, H., Fan, C., Xie, J., & Wang, J. (2020) · doi:10.21203/rs.3.rs-25260/v1
Ageing and Mild Cognitive Impairment (MCI)
Crichton, R. R., & Ward, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118553480.ch05
Galazka-Friedman, J., Friedman, A., & Bauminger, E. R. (2009) · Springer eBooks · doi:10.1007/978-3-642-01370-6_4
Novel Approaches to PET Imaging Neurodegeneration
Tanzey, S. S. (2021) · Deep Blue (University of Michigan) · doi:10.7302/1411
Levodopa Therapy for the Treatment of Parkinson’s Disease
Hattori, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_225
Znaidi, R. (2023) · theses.fr (ABES) · doi:10.70675/fc5affbdz1b90z4faaza5eczde1aaa097238
Feng, H., Tu, N., Wang, K., Ma, X., Zhang, Z., Liu, Z., Cheng, Z., & Bu, L. (2024) · EJNMMI Research · doi:10.1186/s13550-024-01136-z
RetractedBerro, Z., Subirana, M. A., Warres, C., Wirtz, T., Taubitz, T., Audinot, J., Zucca, F. A., Mittelbronn, M. G. A., Zecca, L., & Biesemeier, A. (2024) · BIO Web of Conferences · doi:10.1051/bioconf/202412915009
Self-citationRemédiation olfactive connectée : impact sur la cognition et le bien-être
Moussy, E. (2024) · theses.fr (ABES) · doi:10.70675/8ce5b314zf997z4711zae4ezcbb8dad6e425
Molecular phenotyping of Parkinson's disease
Lee, K. W. (2025) · doi:10.69622/28760255
Parkinson’s disease: A preventable consequence of oxidative stressPreprint
Nadeau, B., & Dowle, G. (2025) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/59wmh_v1
Moreira, I. P., Serrão, P., Sequeira, L., Sá, M. J., Guimarães, J., & Vieira‐Coelho, M. A. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2554527
Wallstein, N., Capucciati, A., Pöppl, A., Schnohr, C. S., Sturini, M., Pampel, A., Jäger, C., Zecca, L., Zucca, F. A., Monzani, E., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202509102
Self-citationNeuromelanin-targeted 18F-P3BZA PET/MR imaging of the substantia nigra in rhesus macaques
Feng, H., Tu, N., Wang, K., Ma, X., Zhang, Z., Liu, Z., Cheng, Z., & Bu, L. (2025) · EJNMMI Research · doi:10.1186/s13550-025-01297-5
The quest for the best: manual, atlas- and spatial prior-based delineation of locus coeruleus
Dmitrichenko, O., Baldizzi, G., Schmidt, T., Bussy, A., Colliot, O., Lutti, A., Kherif, F., & Draganski, B. (2026) · NeuroImage Clinical · doi:10.1016/j.nicl.2026.104039
Neurological aging and neurodegenerative disease in humans and great apes
Edler, M. K., Hearn, C. J., Guevara, E. E., Mhatre‐Winters, I., Varghese, M., Freire‐Cobo, C., Sherwood, C. C., Richardson, J. R., Raghanti, M. A., & Hof, P. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27380-3.00074-9 · Cited by 1
Excess iron may accelerate amyloid beta accumulation in the brains of older mice
Song, S., & Shin, J. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.12.003
Michniewicz, F. (2023) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/24867
Metadata
- Authors
- Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., Karatekin, E., Kleinman, M. H., Turro, N., Hornykiewicz, O., & Zucca, F. A.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Vienna (AT)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-06-21
- Volume
- 101
- Issue
- 26
- Pages
- 9843-9848
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC470762
- OpenAlex
- W2116294955
- Cited by
- 495
- References
- 51
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 31 · 2023: 30 · 2022: 37 · 2021: 46 · 2020: 31 · 2019: 41 · 2018: 23 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 18 · 2013: 14 · 2012: 21
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron, copper, locus coeruleus, substantia nigra, Parkinson's disease, neuronal vulnerability, aging, neuromelanin, ferritin, ceruloplasmin, manganese superoxide dismutase, copper-zinc superoxide dismutase, iron mobilization, iron toxicity, brainstem
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Ceruloplasmin, Copper, Electron Spin Resonance Spectroscopy, Female, Ferritins, Homeostasis, Humans, Iron, Iron Chelating Agents, Locus Coeruleus, Male, Melanins, Middle Aged, Neuroglia, Neurons, Substantia Nigra, Superoxide Dismutase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.